Advanced Search

Technical Analysis for PASG - Passage Bio, Inc.

Grade Last Price % Change Price Change
grade A 12.53 -8.07% -1.10
PASG closed down 8.07 percent on Friday, March 27, 2020, on 22 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical PASG trend table...
Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Hot IPO Pullback Bullish Swing Setup -8.07%
Inside Day Range Contraction -14.99%
Up 3 Days in a Row Strength -14.99%
Up 4 Days in a Row Strength -14.99%
Up 5 Days in a Row Strength -14.99%
Shooting Star Candlestick Bearish -10.63%
Gapped Up Strength -10.63%
Up 3 Days in a Row Strength -10.63%
Older EOD signals for PASG ...
View Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
PASG Chart by TradingView
Basic chart:

Profile

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Medicine Health Organ Systems Rare Diseases Lipid Storage Disorders Aditya Kohli Rare Tadataka Yamada

Is PASG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Mar 27 Passage Bio to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
Mar 25 DZ Bank likes Medtronic in premarket analyst action
Mar 25 120 Biggest Movers From Yesterday
Mar 24 75 Stocks Moving In Tuesday's Mid-Day Session
Mar 24 Blair likes Incyte in premarket analyst action
Mar 22 The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus
Mar 19 The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
Mar 10 The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
Mar 9 Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 5 The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
See more PASG news...

Indicators

Indicator Value
52 Week High 23.25
52 Week Low 8.09
Average Volume 344,929
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 15.29
10-Day Moving Average 11.53
Average True Range 2.46
ADX 0.0
+DI 20.03
-DI 31.28
Chandelier Exit (Long, 3 ATRs ) 15.88
Chandelier Exit (Short, 3 ATRs ) 15.46
Upper Bollinger Band 23.68
Lower Bollinger Band 6.89
Percent B (%b) 0.34
BandWidth 109.80
MACD Line -2.04
MACD Signal Line -1.85
MACD Histogram -0.1917
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.02
Resistance 3 (R3) 15.16 14.47 14.61
Resistance 2 (R2) 14.47 13.84 14.40 14.47
Resistance 1 (R1) 13.50 13.44 13.16 13.36 14.33
Pivot Point 12.81 12.81 12.64 12.74 12.81
Support 1 (S1) 11.84 12.18 11.50 11.70 10.73
Support 2 (S2) 11.15 11.78 11.08 10.59
Support 3 (S3) 10.18 11.15 10.46
Support 4 (S4) 10.04